Programme of the conference

25 September 2026Friday
  • 08:50 – 09:00 — Opening of the conference

    Marta Sobas, Jan Styczyński

  • 09:00 – 10:45 — Session 1 | Therapy of AYA MPN

    Chair: Tomasz Sacha and Krzysztof Lewandowski

  • 09:00 – 09:20 — Therapy of children, adolescents and young adults with CML and MPN Ph-neg. (15 min. lectures + 5 min. discussion)

    Tomasz Sacha, Department of Hematology, Jagiellonian University Hospital, Kraków, Poland.

  • 09:20 – 09:40 — Therapy of mastocytosis in children, adolescents and young adults. (15 min. lectures + 5 min. discussion)

    Aneta Szudy-Szczyrek, Department of Hematooncology and Bone Marrow Transplantation, Medical University Hospital, Lublin, Poland.

  • 09:40 – 10:00 — Can we use JAK2 and CALR variant allele fraction in daily clinical practice? (15 min. lectures + 5 min. discussion)

    Krzysztof Lewandowski, Hematology and Bone Marrow Transplantation Department, University of Medical Sciences, Poznan, Poland.

  • 10:00 – 10:20 — Outcomes of allogeneic haematopoietic cell transplantation for myelofibrosis in children and adolescents. (15 min. lectures + 5 min. discussion)

    Jacek Wachowiak, Department of Pediatric Oncology, Hematology and Transplantology, University of Medical Sciences, Poznan, Poland.

  • 10:20 – 10:30 — Oral presentation 1 (7 min. lecture + 3 min. discussion)
  • 10:30 – 10:45 — Discussion
  • 10:45 – 11:00 — Coffee break
  • 11:00 – 12:25 — Session 2 | Diagnosis of AYA MPN

    Chair: Mary Frances McMullin and Alessandro Lucchesi

  • 11:00 – 11:20 — How bone marrow trephine biopsy can help in diagnosis of thrombocytosis or polyglobulia in children and young adults. (15 min. lectures + 5 min. discussion)

    Krzysztof Zduniak, Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii, Wrocław, Poland; Magdalena Łozińska, Children’s Regional Hospital in Olsztyn, Poland.

  • 11:20 – 11:40 — How to diagnose and manage hereditary erythrocytosis. (15 min. lectures + 5 min. discussion)

    Mary Frances McMullin, Department of Hematology, Queen’s University, Belfast, Northern Ireland, UK.

  • 11:40 – 12:00 — Can artificial intelligence make diagnosis and management of young hematological patients more efficient? (15 min. lectures + 5 min. discussion)

    Alessandro Lucchesi, Hematology Unit – IRST IRCCS, Meldola, Italy and Fabio Gori, Pistoia Analytics, Hague, Netherlands.

  • 12:00 – 12:10 — Oral presentation 2 (7 min. lecture + 3 min. discussion)
  • 12:10 – 12:25 — Discussion
  • 12:25 – 12:40 — Coffee break
  • 12:40 – 13:45 — Session 3 | More novelties in AYA MPN

    Chair: Jennifer O”Sullivan and Tata Negeswera Rao

  • 12:40 – 13:00 — Can we stop disease progression in AYA MPN patients? (15 min. lectures + 5 min. discussion)

    Jennifer M O’Sullivan, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom.

  • 13:00 – 13:20 — MPN and aging. (15 min. lectures + 5 min. discussion)

    Tata Nageswera Rao, Laboratory of Stem Cells and Cancer Biology, Division Oncology and Hematology, HOCH Health Ostschweiz, Cantonal Hospital St. Gallen, Switzerland.

  • 13:20 – 13:30 — Oral presentation 3 (7 min. lecture + 3 min. discussion)
  • 13:30 – 13:45 — Discussion
  • 13:45 – 14:45 — Lunch break
  • 14:45 – 16:50 — Session 4 | Pregnancy and fertility in oncohematology

    Chair: David Allsup and Marta Sobas

  • 14:45 – 15:05 — CML pregnancy and procreation recommendations. (15 min. lectures + 5 min. discussion)

    Joanna Góra-Tybor, Department of Hematooncology, Copernicus Memorial Hospital, Medical University of Lodz, Poland.

  • 15:05 – 15:25 — Management of pregnancy in MPN-Ph neg. (15 min. lectures + 5 min. discussion)

    Marta Sobas, Department of Hematology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Torun, Jan Biziel University Hospital No. 2 in Bydgoszcz, Poland.

  • 15:25 – 15:45 — Pregnancy in leukemias and lymphomas. (15 min. lectures + 5 min. discussion)

    David Allsup, Department of Hematology, Hull University Teaching Hospitals NHS Trust, Hull, UK; Centre for Biomedicine, Hull York Medical School, Hull, UK.

  • 15:45 – 16:05 — Bleeding and thrombotic events – how to manage during pregnancy. (15 min. lectures + 5 min. discussion)

    Jireh Ann Batac, Hull University Teaching Hospitals NHS Trust.

  • 16:05 – 16:25 — Male fertility in oncohematology. (15 min. lectures + 5 min. discussion)

    Bartosz Brzoszczyk, Clinic of Urology, Jan Biziel University Hospital No. 2 in Bydgoszcz, Bydgoszcz, Poland.

  • 16:25 – 16:35 — Oral presentation 4 (7 min. lecture + 3 min. discussion)
  • 16:35 – 16:50 — Discussion
  • 16:50 – 17:05 — Coffee break
  • 17:05 – 18:50 — Session 5 | Resilience and Genetic Predisposition in MDS

    Chair: Tomasz Stokłosa and Dan H. Wiseman

  • 17:05 – 17:25 — How to treat MDS in young adults? (15 min. lectures + 5 min. discussion)

    Krzysztof Mądry, Department of Haematology, Transplantation and Internal Medicine, Warszawa Medical University, Warsaw, Poland.

  • 17:25 – 17:45 — Can we change the future of therapy of pediatric and young myelodysplastic/myeloproliferative neoplasms? (15 min. lectures + 5 min. discussion)

    Dan H. Wiseman, Epigenetics of Haematopoiesis Group, The University of Manchester, UK.

  • 17:45 – 18:05 — Genome-wide methylation in MDS – diagnostic and clinical implications. (15 min. lectures + 5 min. discussion)

    Artur Kowalik, Department of Molecular Diagnostics, Holycross Cancer Center, Kielce, Poland.

  • 18:05 – 18:25 — Genetic predisposition syndromes: when should they be considered in the work-up of MDS? (15 min. lectures + 5 min. discussion)

    Tomasz Stokłosa, Department of Tumor Biology and Genetics, Medical University of Warsaw, Warsaw, Poland.

  • 18:25 – 18:35 — Oral presentation 5 (7 min. lecture + 3 min. discussion)
  • 18:35 – 18:50 — Discussion
  • 09:00 – 20:00 — Parallel poster session
  • 19:00 — Dinner (Hotel City)
26 September 2026Saturday
  • 08:40 – 10:45 — Session 6 | Management of younger patients with lymphomas

    Chair: Krzysztof Giannopoulos and Grzegorz Basak

  • 08:40 – 09:00 — Are there any differences between lymphomas in children and adults? (15 min. lectures + 5 min. discussion)

    Elżbieta Latos-Grażyńska, Department of Pediatric Bone Marrow Transplantation, Oncology and Hematology, Wroclaw Medical University, Poland.

  • 09:00 – 09:20 — Is indolent lymphoma in young patients indolent? (15 min. lectures + 5 min. discussion)

    Joanna Drozd-Sokołowska, Department of Haematology, Transplantation and Internal Medicine, Warszawa Medical University, Warsaw, Poland.

  • 09:20 – 09:40 — Optimizing lymphoma therapy in young patients: balancing efficacy and long-term toxicity? (15 min. lectures + 5 min. discussion)

    Krzysztof Giannopoulos, Experimental Hematooncology Department, Medical University of Lublin, Lublin, Poland; Hematology Department, St John’s Cancer Centre, Lublin, Poland.

  • 09:40 – 10:00 — CAR-T as a future for therapy of young DLBCL patients? (15 min. lectures + 5 min. discussion)

    Grzegorz Basak, Department of Haematology, Transplantation and Internal Medicine, Warszawa Medical University, Warsaw, Poland.

  • 10:00 – 10:20 — Are there any differences in the treatment of younger versus older patients with Hodgkin lymphoma? (15 min. lectures + 5 min. discussion)

    Andrzej Frygier, Department of Hematology, Hull University Teaching Hospitals NHS Trust, Hull, UK; Centre for Biomedicine, Hull York Medical School, Hull, UK.

  • 10:20 – 10:30 — Oral presentation 6 (7 min. lecture + 3 min. discussion)
  • 10:30 – 10:45 — Discussion
  • 10:45 – 11:00 — Coffee break
  • 11:00 – 12:25 — Session 7 | Thrombosis and Bleeding in young patients

    Chair: Jerzy Windyga and Chloe James

  • 11:00 – 11:20 — Thrombotic events in young MPN. (15 min. lectures + 5 min. discussion)

    Chloe James, University of Bordeaux, Institut national de la santé et de la recherche médicale, Biologie des maladies cardio-vasculaires, U1034. Laboratory of Hematology, Bordeaux University Hospital, Pessac.

  • 11:20 – 11:40 — Portal vein thrombosis and PNH in young patients. (15 min. lectures + 5 min. discussion)

    Agnieszka Piekarska, Dept of Haematology and Transplantology, Medical University of Gdansk, Gdansk, Poland.

  • 11:40 – 12:00 — How to diagnose and manage cTTP? (15 min. lectures + 5 min. discussion)

    Jerzy Windyga, Department of Hemostasis Disorders and Internal Medicine, Laboratory of Hemostasis and Metabolic Diseases, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.

  • 12:00 – 12:10 — Oral presentation 7 (7 min. lecture + 3 min. discussion)
  • 12:10 – 12:25 — Discussion
  • 12:25 – 12:40 — Coffee break
  • 12:40 – 14:05 — Session 8 | Acute Lymphoblastic Leukemia in children, adolescents and young adults

    Chair: Sebastian Giebel and Jan Styczyński

  • 12:40 – 13:00 — Adult and childhood B-ALL: same but different. (15 min. lectures + 5 min. discussion)

    Sebastian Giebel, The Department of Bone Marrow Transplantation and Onco-Hematology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.

  • 13:00 – 13:20 — T-ALL in children, adolescents and young adults. (15 min. lectures + 5 min. discussion)

    Wojciech Młynarski, Department of Paediatrics, Oncology, Haematology and Diabetology, Medical University of Lodz, Lodz Poland

  • 13:20 – 13:40 — How I manage long-term survivors of childhood and young adult acute lymphoblastic leukemia. (15 min. lectures + 5 min. discussion)

    Jan Styczyński, Department of Pediatric Hematology and Oncology, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland.

  • 13:40 – 13:50 — Oral presentation 8 (7 min. lecture + 3 min. discussion)
  • 13:50 – 14:05 — Discussion
  • 14:05 – 15:00 — Lunch break
  • 15:00 – 17:05 — Session 9 | Acute Myeloid Leukemia in younger patients

    Chair: Lars Bullinger and Agnieszka Wierzbowska

  • 15:00 – 15:20 — Pediatric AML: state of the Art and Future Directions. (15 min. lectures + 5 min. discussion)

    Robert Dębski, Department of Pediatric Hematology and Oncology, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland.

  • 15:20 – 15:40 — How to manage short- and long-term cardiotoxicity in AML/APL. (15 min. lectures + 5 min. discussion)

    Sebastian Szmit, Department of Pulmonary Circulation, Thromboembolic Diseases, and Cardiology, Center of Postgraduate Medical Education, European Health Center, Otwock, Poland. Department of Cardio-Oncology, Center of Postgraduate Medical Education, Warsaw, Poland.

  • 15:40 – 16:00 — Genetic basis of „secondary” AML. (15 min. lectures + 5 min. discussion)

    Lars Bullinger, Department of Hematology, Oncology and Cancer Immunology, Campus Virchow, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany.

  • 16:00 – 16:20 — How to treat fit younger patients with „secondary” AML. (15 min. lectures + 5 min. discussion)

    Agnieszka Wierzbowska, Department of Hematooncology, Copernicus Memorial Hospital, Medical University of Lodz, Poland.

  • 16:20 – 16:30 — Oral presentation 9 (7 min. lecture + 3 min. discussion)
  • 16:30 – 16:45 — Discussion
  • 16:45 – 17:00 — Coffee break
  • 17:00 – 19:00 — Session 10 | Multiple Myeloma in younger patients

    Chair: Guy Pratt and Krzysztof Jamroziak

  • 17:00 – 17:20 — How to manage young smoldering MM patient. (15 min. lectures + 5 min. discussion)

    Krzysztof Jamroziak, Department of Haematology, Transplantation and Internal Medicine, Warszawa Medical University, Warsaw, Poland.

  • 17:20 – 17:40 — How to manage young MM patient. (15 min. lectures + 5 min. discussion)

    Guy Pratt, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.

  • 17:40 – 18:00 — CAR-T cell therapy in multiple myeloma: mission accomplished. (15 min. lectures + 5 min. discussion)

    Andrzej Jakubowiak, The University of Chicago, Poznan University of Medical Sciences.

  • 18:00 – 18:10 — Oral presentation 10 (7 min. lecture + 3 min. discussion)
  • 18:10 – 18:25 — Discussion
  • 18:25 – 18:45 — An European Network for Teenagers and Young Adults with Cancer. (15 min. lectures + 5 min. discussion)

    Anna Castleton, The Christie Hospital NHS Trust, Manchester, UK.

  • 09:00 – 20:00 — Parallel poster session
  • 18:45 – 19:00 — Discussion
  • 19:00 – 19:15 — CLOSE OF THE CONFERENCE

    Marta Sobas and Jan Styczyński

  • 20:00 — Dinner

Organizer

JMJ Sp. z o.o.
6/49 Bachmacka Street
02-647 Warsaw
VAT ID: 554 21 98 780

Contact:
Jowita Bąk
e-mail: jowita.bak@jmjkonferencje.pl
phone: +48 501 032 095